Supplier analysis

American Peptides

americanpeptides.us

Confidence BoperatingReviewed 2026-08-25
RSES v1.08.1/ 10

RSES scope. RSES evaluates publicly available research-supplier documentation. It does not guarantee product identity, safety, sterility, future-lot consistency, regulatory compliance, or suitability for human use. Research-use-only labeling is not a safety finding.

RSES interpretationconditional qualification
Category ratings

Documentation evidence profile

Analytical evidence4.6 / 5 · 28%
Lot traceability and sampling4.5 / 5 · 18%
Laboratory and method credibility4.0 / 5 · 14%
Contamination controls3.8 / 5 · 12%
Cross-lot consistency4.2 / 5 · 8%
Corporate transparency3.8 / 5 · 7%
Catalog accuracy3.2 / 5 · 5%
Corrective-action record2.0 / 5 · 4%
Community signal2.5 / 5 · 4%
Evidence sources

Documentation reviewed

[Marketing claim]

Buttondown / PeptideDr signal

Evidence class: Marketing claim. Source-list position: 2. Affiliate disclosure recorded; retained as a third-party source signal only.

Open evidence source
[Third-party document review]

Independent documentation review

Evidence class: Third-party document review. Peptigrity preserves vendor-attributed Bioviridian reports; Public library exposed 126 lot-matched certificates at review

Source URL unavailable in the dataset